Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics
Conclusion: Comprehensive understanding of the mechanisms underlying obesity-related high onclopidogrel platelet reactivity will help in the optimization of antithrombotic therapy in this patient population.
Source: Drug Metabolism Letters - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Clopidogrel | Drugs & Pharmacology | Eating Disorders & Weight Management | Heart | Insulin | Obesity | Plavix